An Overview of Drug Combination Analysis with Isobolograms
Top Cited Papers
- 1 October 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (1) , 1-7
- https://doi.org/10.1124/jpet.106.104117
Abstract
Drugs given in combination may produce effects that are greater than or less than the effect predicted from their individual potencies. The historical basis for predicting the effect of a combination is based on the concept of dose equivalence; i.e., an equally effective dose (a) of one will add to the dose (b) of the other in the combination situation. For drugs with a constant relative potency, this leads to linear additive isoboles (a-b curves of constant effect), whereas a varying potency ratio produces nonlinear additive isoboles. Determination of the additive isobole is a necessary procedure for assessing both synergistic and antagonistic interactions of the combination. This review discusses both variable and constant relative potency situations and provides the mathematical formulas needed to distinguish these cases.This publication has 17 references indexed in Scilit:
- Assessment of Drug Interactions Relevant to Pharmacodynamic Indirect Response ModelsJournal of Pharmacokinetics and Pharmacodynamics, 2004
- Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved IsobolesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Neostigmine interactions with non steroidal anti‐inflammatory drugsBritish Journal of Pharmacology, 2002
- N-Methyl-d-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6 H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic HypothermiaThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Synergy between μ Opioid Ligands: Evidence for Functional Interactions among μ Opioid Receptor SubtypesThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic PainThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned ratPsychopharmacology, 1997
- Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and sub-additivityLife Sciences, 1992
- Die quantitativen Probleme der PharmakologiePublished by Springer Nature ,1928
- Die MischarzneiJournal of Molecular Medicine, 1927